Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: A workshop summary

Regulatory Toxicology and Pharmacology

Volumn 68, Issue 1, 2014, Pages 96-107

  Boverhof, Darrell R ^a   Ladics, Greg ^b   Luebke, Bob ^c   Botham, Jane ^d   Corsini, Emanuela ^e   Evans, Ellen ^f   Germolec, Dori ^g   Holsapple, Michael ^h   Loveless, Scott E ^b   Lu, Haitian ⁱ   van der Laan, Jan Willem ^j   White, Kimber L ^k   Yang, Yung ^c  

^a DOW CHEMICAL COMPANY   (United States)

^b DUPONT COMPANY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

^f PFIZER INC   (United States)

^g NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^h BATTELLE MEMORIAL INSTITUTE   (United States)

ⁱ DOW AGROSCIENCES LLC   (United States)

^j MEDICINES EVALUATION BOARD   (Netherlands)

^k ImmunoTox Inc   (United States)

more..

Author keywords

Environmental chemicals; Immunotoxicity; Testing

Indexed keywords

ENVIRONMENTAL CHEMICAL;

ANIMAL USE; ARTICLE; CHEMICAL INDUSTRY; DEVELOPMENTAL IMMUNOTOXICITY; DRUG INDUSTRY; EXPOSURE; HUMAN; IMMUNE DEFICIENCY; IMMUNOTOXICITY; IN VITRO STUDY; INFORMATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; TOXICITY TESTING; WORKSHOP;

2,4-D; 2,4-DICHLOROPHENOXYACETIC ACID; ACD; ACSA; AFC; AGRICULTURAL CHEMICAL SAFETY ASSESSMENT; ALLERGIC CONTACT DERMATITIS; ANTIBODY FORMING CELL; CARBON TETRACHLORIDE; CP; CT; CYCLOPHOSPHAMIDE; DART; DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY; DEVELOPMENTAL IMMUNOTOXICITY; DIT; DUTCH NATIONAL INSTITUTE OF PUBLIC HEALTH AND THE ENVIRONMENT; ELISA; ENVIRONMENTAL CHEMICALS; ENVIRONMENTAL PROTECTION AGENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOGRTS; EPA; EU; EUROPEAN UNION; EXTENDED ONE-GENERATION REPRODUCTIVE TOXICITY STUDY; FDA; FOOD AND DRUG ADMINISTRATION; HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE; HESI; ICH; ILSI; IMMUNOTOXICITY; INTERNATIONAL CONFERENCE ON HARMONIZATION; INTERNATIONAL LIFE SCIENCES INSTITUTE; KEYHOLE LIMPET HEMOCYANIN; KLH; LLNA; LOCAL LYMPH NODE ASSAY; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES; NATIONAL RESEARCH COUNCIL; NATIONAL TOXICOLOGY PROGRAM; NATURAL KILLER; NIEHS; NIOSH; NK; NO OBSERVED ADVERSE EFFECT LEVEL; NOAEL; NRC; NTP; OECD; ORGANISATION FOR ECONOMIC COOPERATION AND DEVELOPMENT; PND; POSTNATAL DAY; RIVM; SHEEP RED BLOOD CELLS; SRBC; STANDARD TOXICOLOGY STUDIES; STS; T-CELL DEPENDENT ANTIBODY REACTION; TDAR; TESTING; UNITED STATES; US; WEIGHT-OF-EVIDENCE; WOE;

ANIMALS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; IMMUNE SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84890284139     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.11.012     Document Type: Article

References (77)

1. Adler S., et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 2011, 85:367-485.
2. Aeby P., et al. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol. In Vitro 2010, 24:1465-1473.
3. Andersen M.E., Krewski D. The vision of toxicity testing in the 21st century: moving from discussion to action. Toxicol. Sci. 2010, 117:17-24.
4. Basketter D., et al. Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern. Lab. Anim. 2007, 35:137-154.
5. Billington R., et al. The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides. Crit. Rev. Toxicol. 2010, 40:35-49.
6. Bugelski P.J., et al. Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int. J. Toxicol. 2010, 29:435-466.
7. Bunn T.L., et al. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 2001, 64:57-66.
8. Burns-Naas L.A., et al. What's so special about the developing immune system?. Int. J. Toxicol. 2008, 27:223-254.
9. Casati S., et al. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern. Lab. Anim. 2005, 33:47-62.
10. Chapin R.E., et al. The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundam. Appl. Toxicol. 1997, 40:138-157.
11. Cooper R.L., et al. A tiered approach to life stages testing for agricultural chemical safety assessment. Crit. Rev. Toxicol. 2006, 36:69-98.
12. Corsini E., Roggen E.L. Immunotoxicology: opportunities for non-animal test development. Altern. Lab. Anim. 2009, 37:387-397.
13. Dellarco V.L., et al. A retrospective analysis of toxicity studies in dogs and impact on the chronic reference dose for conventional pesticide chemicals. Crit. Rev. Toxicol. 2010, 40:16-23.
14. DeWitt J.C., et al. Current status of developmental immunotoxicity: early-life patterns and testing. Toxicol. Pathol. 2012, 40:230-236.
15. Dietert R.R., et al. Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group summary. Environ. Health Perspect. 2000, 108(Suppl 3):483-490.
16. dos Santos G.G., et al. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 2009, 236:372-382.
17. Fegert I., et al. Feasibility of the extended one-generation reproductive toxicity study (OECD 443). Reprod. Toxicol. 2012, 34:331-339.
18. Fischer A., et al. Specific antibody responses of primary cells from different cell sources are able to predict immunotoxicity in vitro. Toxicol. In Vitro 2011, 25:1966-1973.
19. Galbiati V., et al. Present and future of in vitro immunotoxicology in drug development. J. Immunotoxicol. 2010, 7:255-267.
20. Gehen, S. C., et al., in submission. Retrospective evaluation of the impact of functional immunotoxicity testing on pesticide hazard identification and risk assessment.
21. Gehrs B.C., Smialowicz R.J. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 1999, 134:79-88.
22. Gennari A., et al. The use of in vitro systems for evaluating immunotoxicity: the report and recommendations of an ECVAM workshop. J. Immunotoxicol. 2005, 2:61-83.
23. Gerberick F., et al. Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM workshop 64. Altern. Lab. Anim. 2008, 36:215-242.
24. Gore E.R. Immune function tests for hazard identification: a paradigm shift in drug development. Basic Clin. Pharmacol. Toxicol. 2006, 98:331-335.
25. Haglund C., et al. The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. Toxicol. Lett. 2010, 194:102-107.
26. Holsapple M.P. Developmental immunotoxicology and risk assessment: a workshop summary. Hum. Exp. Toxicol. 2002, 21:473-478.
27. Holsapple M.P. Developmental immunotoxicity testing: a review. Toxicology 2003, 185:193-203.
28. Holsapple M.P., et al. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol. Sci. 2005, 83:18-24.
29. Holsapple M.P., et al. Symposium summary: children's health risk-what's so special about the developing immune system?. Toxicol. Appl. Pharmacol. 2004, 199:61-70.
30. Holsapple M.P., et al. Development of a framework for developmental immunotoxicity (DIT) testing. Immunotoxicology and Immunopharmacology 2007, 347-361. CRC Press, Boca Raton. R. Luebke (Ed.).
31. House R.V. An overview of in vitro/ex vivo assays for preclinical evaluation of immunomodulation. Hum. Exp. Toxicol. 2000, 19:246-250.
32. IARC, 2006. Inorganic and Organic Lead Compounds. vol. 87. World Health Organization International Agency for Research on Cancer, Lyon, France.
33. Harmonised tripartite guideline: immunotoxicity studies for human pharmaceuticals 2005, S8. ICH.
34. Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 1998, 125:183-201. ICICIS Group Investigators.
35. Kimber I., Weisenberger C. A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study. Arch. Toxicol. 1989, 63:274-282.
36. Koeper L.M., Vohr H.W. Functional assays are mandatory for a correct prediction of immunotoxic properties of compounds in vitro. Food Chem. Toxicol. 2009, 47:110-118.
37. Ladics G.S. Primary immune response to sheep red blood cells (SRBC) as the conventional T-cell dependent antibody response (TDAR) test. J. Immunotoxicol. 2007, 4:149-152.
38. Ladics G.S., et al. Developmental toxicology evaluations-issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol. Sci. 2005, 88:24-29.
39. Ladics G.S., et al. Characterization of an approach to develoopmental immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol. Mech. Methods 2000, 10:283-311.
40. Ladics G.S., et al. Further evaluation of the incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology 1998, 126:137-152.
41. Ladics G.S., et al. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 1995, 96:225-238.
42. Luebke R. Immunotoxicant screening and prioritization in the twenty-first century. Toxicol. Pathol. 2012, 40:294-299.
43. Luebke R.W., et al. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health B Crit. Rev. 2006, 9:1-26.
44. Luster M.I., et al. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 2003, 111:579-583.
45. Luster M.I., et al. Development of a testing battery to assess chemical-induced immunotoxicity: national toxicology program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 1988, 10:2-19.
46. Luster M.I., et al. Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology. Toxicol. Lett. 1992, 64-65:71-78. Spec No.
47. Luster M.I., et al. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 1993, 21:71-82.
48. Luster M.I., et al. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 1992, 18:200-210.
49. Martin S.F., et al. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell. Mol. Life Sci. 2010, 67:4171-4184.
50. Marty, M. S., Neal, B.H., Zablotny, C.L., Yano, B.L., Andrus, A.K., Woolhiser, M.R., Boverhof, D.R., Saghir, S.A., Perala, A.W., Passage, J.K., Lawson, M.A., Bus, J.S., Lamb, J.C., and L. Hammond, 2013. An F1-extended one generation reproductive toxicity study (EOGRTS) in CRL:CD(SD) rats with 2,4-dichlorophenoxyacetic acid (2,4-D). in submission.
51. Miller T.E., et al. Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci. 1998, 42:129-135.
52. NRC Toxicity Testing in the 21st Century: A Vision and a Strategy 2007, National Academies Press, Washington, DC.
53. Guideline for the Testing of Chemicals 421: Reproduction/Developmental Toxicity Screening Test 1995, OECD, Organisation for Economic Cooperation and Development, Paris, France.
54. Guideline for the Testing of Chemicals 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test 1996, OECD, Organisation for Economic Cooperation and Development, Paris, France.
55. Guideline for the Testing of Chemicals 428: Skin Absorpotion. In Vitro Method 2004, OECD, Organisation for Economic Cooperation and Development, Paris, France.
56. Draft Guidance Document 151 in Support of OECD Test Guideline 443 on an Extended one Generation Reproductive Toxicity Study 2011, OECD, Organisation for Economic Cooperation and Development, Paris, France.
57. OECD, 2011b. Guidance Document 117 on the Current Implementation of Internal Triggers in Test Guideline 443 for an Extended one Generation Reproductive Toxicity Study in the United States and Canada., vol. 117.
58. Guideline for the Testing of Chemicals 443: Extended One-Generation Reproductive Toxicity Study 2011, OECD, Organisation for Economic Cooperation and Development, Paris, France.
59. Patlewicz G., et al. An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential. SAR QSAR Environ. Res. 2007, 18:515-541.
60. Patlewicz G.Y., Lander D.R. A step change towards risk assessment in the 21st century. Front Biosci. (Elite Ed). 2013, 5:418-434.
61. Pessina A., et al. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol. In Vitro 2001, 15:729-740.
62. Piersma A.H., et al. Combined retrospective analysis of 498 rat multi-generation reproductive toxicity studies: on the impact of parameters related to F1 mating and F2 offspring. Reprod. Toxicol. 2011, 31:392-401.
63. Richter-Reichhelm H.B., et al. Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system. Regul. Toxicol. Pharmacol. 1995, 22:54-56.
64. Rorije E., et al. On the impact of second generation mating and offspring in multi-generation reproductive toxicity studies on classification and labelling of substances in Europe. Regul. Toxicol. Pharmacol. 2011, 61:251-260.
65. Smialowicz R.J., et al. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats. Toxicol. Appl. Pharmacol. 1994, 124:248-256.
66. Smialowicz R.J., et al. The effects of perinatal/juvenile heptachlor exposure on adult immune and reproductive system function in rats. Toxicol. Sci. 2001, 61:164-175.
67. Takahashi T., et al. An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8. Toxicol. Sci. 2011, 124:359-369.
68. US EPA, OPPTS Harmonized Test Guideline: OPPTS 870.7800. Immunotoxicity. EPA/712/C- 98/351. United States Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Washington, DC, 1998.
69. US EPA, 2007. Environmental Protection Agency, 40 CFR Parts 9 and 158. Pesticides; Data Requirements for Conventional Chemicals. Federal Register, Vol. 72, No 207 / Friday, October 26.
70. US EPA, 2013. A Retrospective Analysis of the Immunotoxicity Studies (OCSPP Test Guildeline No. 870.7800). United States Environmental Protection Agency, Health Effects Division, Office of Pesticide Programs.
71. van Loveren H., Vos J.G. Immunotoxicological considerations: a practical approach to immunotoxicity testing in the rat. Advances in Applied Toxicology 1989, 143-165. Taylor & Francis, London. A.D. Dayan, A.J. Paine (Eds.).
72. Vos J.G. Immune suppression as related to toxicology. CRC Crit. Rev. Toxicol. 1977, 5:67-101.
73. Vos J.G. Immunotoxicity assessment: screening and function studies. Arch. Toxicol. Suppl. 1980, 4:95-108.
74. Vos, J.G., Van Loveren, H., 1987. Immunotoxicity Testing. In: Burger, E.J., et al., (Eds.), The Rat. Advances In Modern Environmental Toxicology. vol. 13. Princeton Scientific Publishing, Princeton, N.J., pp. 167-180.
75. Weaver J.L., et al. Development of the ICH guidelines for immunotoxicology evaluation of pharmaceuticals using a survey of industry practices. J. Immunotoxicol. 2005, 2:171-180.
76. White K.L. Validation: state of the art United States national toxicology program & fischer 344 rat cyclosporine-a study. J. Toxicol. Clin. Exp. 1992, 12:429-447.
77. Woolhiser, M.R., et al., 2007. Feasibility study to conduct the antibody plaque-forming cell assay and spleen histopathology simultaneously using Fischer 344 rats. 46th Annual Meeting of the Society of Toxicology, Charlotte, NC.